An estimated 37 million Americans live with chronic kidney disease (CKD) and nearly 700,000 have end stage renal disease (ESRD). Treatment can be challenging and costly for both patients and payers. In fact, dialysis alone costs Medicare approximately $120 billion annually. Yet, despite the enormous cost, patient outcomes are poor, with nearly one in six dialysis patients dying in the first year after starting treatment.
At CVS Health, we are working to fundamentally transform the treatment paradigm for the millions of patients with CKD and ESRD through CVS Kidney Care, a CVS Health company. Specifically, our CKD management program is focused on early identification of kidney disease, targeted patient engagement and ongoing education to help slow disease progression.